News
SK bioscience Announces Approval of Its Quadrivalent Influenza Vaccine in Indonesia
This approval paves the way for exports to the world's fourth most populous country. SK bioscience aims to continue to grow as a global vaccine brand beyond Korea. SEONGNAM, South Korea, Oct. 23, 2024 /PRNewswire/ -- SK bioscience, a global innovativ
By: prnewswire_apac
- Oct 23 2024
- 0
- 0 Views
ONLY AVAILABLE IN PAID PLANS